Study of Hypotensive Hematopoietic Malignancy Patients' USCOM Readings



Status:Completed
Conditions:Blood Cancer, Lymphoma, Hematology, Leukemia
Therapuetic Areas:Hematology, Oncology
Healthy:No
Age Range:18 - Any
Updated:11/30/-0001
Start Date:December 2012
End Date:August 2013
Contact:Michelle Parmentier, RN, BSN
Email:mbh4152@bjc.org
Phone:314-454-7274

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Pilot Feasibility Study of Hypotensive Hematopoietic Malignancy Patients' USCOM Readings


The purpose of this study is to test how practical it is to use the Ultrasonic Cardiac
Output Monitor (USCOM), an FDA-approved device, on oncology patients (specifically those
with blood cancers). Additionally, the researchers will learn if the USCOM gives additional
information about patients' conditions when their blood pressures drop and they are treated
with intravenous fluids.


Inclusion Criteria:

-≥ 18 years of age

- English speaker

- Diagnosis of blood dyscrasia, hematopoietic malignancy, or condition that may
requires HSCT

Exclusion Criteria:

- Obstruction of the suprasternal notch that prevents placing the USCOM probe in the
correct location

- Tracheostomy or endotracheal tube that prevents placing USCOM probe in the correct
location

- Inability to lie flat, on left or right side, or with the head of bed at a 30 degree
angle for the USCOM exam (ex. due to respiratory distress or physiologic reasons)

- Impairment by a psychiatric, cognitive, or physiologic disorder that limits ability
to understand explanation of study and give consent
We found this trial at
1
site
Washington University School of Medicine
660 S Euclid Ave
Saint Louis, Missouri 63110
(314) 362-5000
Washington University School of Medicine Washington University Physicians is the clinical practice of the School...
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials